Very excited to have this out! My first solo first author publication, encapsulating the majority of my thesis work, on how Senescent-like microglia limit remyelination through the senescence associated secretory phenotype, now on biorxiv.

biorxiv.org/content/10.110…

Scientists in Iran have discovered a new way to convert astrocytes into oligodendrocytes, the cells that make and repair myelin in the brain. bit.ly/3UTj9VM

#MS #MultipleSclerosis #MS Research #MS News

Once thought to be a static structure, mature myelin made by oligodendrocytes has been full of surprises. Check out our new review on the topic!

Had the honor of attending the ACTRIMS® Young Scientist Summit where I learned so much about MS, made lots of new friends/ connections and won best poster award! 🧡

It's #NationalHospitalAwarenessWeek - did you know the Society has a tool for finding MS doctors and resources near you?

Check it out here: ntlms.org/FDR

Our May issue is now live!

nature.com/neuro/volumes/…

Our brain Treg review on the cover of Nature Rev Immunol!

nature.com/articles/s4157…

the topographical model of #MS now published, free/open access:
nn.neurology.org/content/3/5/e2…
Friedman Brain Institute
Neurology Journal

Very excited to see our work published in Nature Medicine today!

A unique autoantibody signature found in some patients w MS - 5 years before onset.

& the target of that autoimmune response bears remarkable similarity to many pathogens - including EBV.

nature.com/articles/s4159…

Are we close to a breakthrough for Multiple Sclerosis?Thanks Tanya Beckett BBC The Inquiry for this informative program and the opportunity to discuss MS treatment and repair strategies with Tim Coetzee Tjalf Ziemssen Claire Shannon-Lowe. #MS #remyelination bbc.co.uk/sounds/play/w3…

Very proud that George Mechor George Melchor successfully defended his PhD thesis on the analysis of #remyelination via single nuc RNA-seq. We've learned that single cell studies are informative but an exhausting endeavor 😀. Congratulations Dr. Melchor on your remarkable

Our latest bioRxiv from Chao Zheng & Bastien Hervé et. al. Karolinska Institutet, multioming oligodendroglia at different stages of the EAE mouse model of multiple sclerosis and finding distinct responses of mature oligodendrocytes

biorxiv.org/content/10.110…

#NewProfilePic

The first cellular map of a mammalian brain is here. 🧠✨

Over 6 years and 32 million cells in the making, the complete adult mouse brain cell-type atlas reveals astonishing diversity and regional specificity.

Dive deeper: alleninstitute.org/scientists-unv…

@nature #studyBRAIN #BICCN

Super cool science and a new neuroprotection target for multiple sclerosis. Will we ever get it into people with MS? #BeyondNEIDA buff.ly/3NQ2sXE

Help me reach my fundraising goal for my first ever BikeMS challenge!

mssociety.donordrive.com/participant/23…

Postdoc is conceptually different from a #PhD position. Below are some key points to keep in mind before starting postdoc.

1️⃣ The harsh reality of being a postdoc:

1. Postdoc is a contractual (not educational) position. Your postdoc duties are defined by your contract &

First, in rats (PMID: 22654062), then in primates (PMID: 27830790), and now in humans (nature.com/articles/s4158…) — this is why we need animal research.

Congrats to G Courtine and cols — impressive work!

Walking naturally after spinal cord injury using a brain–spine interface.

Genentech in a press release announces that Fenebrutinib (a Bruton’s tyrosine kinase (BTK) inhibitor for multiple sclerosis) reduced enhancing MRI lesions in a phase II trial (p=0.0022). Further details will be released shortly. gene.com/media/press-re…

nature.com/articles/d4158…
nature did a nice experiment, revealing both a cause of Alzheimer’s and a cure for: it endowed this patient with a gene that causes AD and at the same time with another gene that protected them for more than two decades